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WHAT HEALTH INFORMATION IS NEEDED TO IMPROVE THE VACCINATION 
OUTCOMES OF COVID-19? : STUDY ANALYSIS  IN COVID-19 VACCINATION IN 
SANGIHE ISLAND REGENCY, INDONESIA 
 











The Indonesian government enforces a COVID-19 vaccination policy for all. Still, the achievement 
rate for the COVID-19 vaccination in Sangihe Islands Regency at the first dose is only 1.05%, while 
the achievement at the second dose to date is only 0.47%. With this in mind, the vaccination policy 
has not been in line with community participation. Therefore, this study aimed to determine what kind 
of health information is needed to increase the covid-19 vaccination rate. The method used in this 
research is a descriptive study with a purposive sampling technique which was held from January 7 to 
February 8, 2021, with a total sample of 85 respondents who are health workers in the Sangihe Islands 
Regency. The data analysis used is descriptive analysis with frequency distribution. The results in this 
study were 15.3% stated that they were not willing to vaccinate COVID-19 because 39% of COVID-
19 survivors, 38% had comorbidities, 15% were unsure of safety, and 8% feared side effects. 
Therefore, the conclusion of this study is to increase health information regarding vaccines for 
COVID-19 survivors, information about comorbidities such as what is appropriate for COVID-19 
vaccination, safety, and side effects resulting from the COVID-19 vaccine. 
 




The number of COVID-19 cases 
globally as of April 26, 2021, was 
146,841,882, with 3,104,743 deaths in these 
cases. Indonesia is ranked 24th globally for 
the most cases of COVID-19, with 1,641,194 
cases (data on April 26, 2021). The number of 
cases is the same as 1.12% of the total cases 
in the world. The number of Case Fatality 
Rates for COVID-19 in Indonesia is 2.71%.1 
The high number of cases made the 
government decide to take serious steps. The 
Indonesian government is trying to deal with 
this problem by making a policy, one of which 
is by vaccinating the people of Indonesia for 
COVID-19 per presidential regulation 
number 14 of 2021 concerning vaccine 
procurement and vaccination in the context of 
tackling the COVID-19 pandemic.2 This 
policy is because the government has 
determined that the COVID-19 pandemic is a 
non-natural disaster included in the national 
disaster category.3 This policy is the 
responsibility taken by the government, which 
is seen as a state-based economic perspective, 
namely placing itself as a center for national 
interests.4 
This policy came into effect in January 
2021, starting with vaccination by the 
President of the Republic of Indonesia, which 
was then gradually carried out to health 
workers as a priority target. In stage 2 
continued targeting public service workers 
and the elderly. After that, the target of the 
third stage was vulnerable people from 
economic, social and the final target is 
continued to the community and other 
economic actors based on the availability of 
vaccines.5 
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The vaccination policy has not been in 
line with community participation. Facts in 
the field as of April 28, 2021, it is known that 
the national level of vaccination against 
COVID-19 for the first dose is only 30.11%, 
while the vaccination for the second dose is 
18.37%. How are vaccinations done in border 
areas? Sangihe archipelago district is one of 
the regencies in North Sulawesi province, 
which directly borders the Philippines. The 
achievement rate for the first dose of 
vaccination is only 1.05%, while the 
achievement in the second dose is only 0.47% 
so far.6  
The low achievement is due to many 
hoaxes regarding vaccination that people in 
border areas also accept. In this district, not all 
regions have access to the internet network. 
Therefore, the most effective health 
information is done manually by word of 
mouth. 
Efforts set by the government to improve 
these achievements are by imposing sanctions 
in the form of termination of social assistance, 
termination of government administration 
services, and even fines for targets who do not 
vaccinate2. In addition to these efforts, an 
effective strategy is also needed to overcome 
these problems. Based on this, the research 
team is interested in knowing what kind of 
health information is required to increase the 
COVID-19 vaccination rate. This research 
can be used as a model in developing health 
education, especially for the community, 
especially in the Sangihe Islands Regency, in 
increasing the number of COVID-19 
vaccination achievements. 
 
MATERIAL AND METHODS 
This research method is a descriptive 
survey. The population in this study was the 
people in the Sangihe Islands Regency. 
Health workers were chosen because they 
were the priority targets for the first stage, and 
then health workers would also be in charge 
of disseminating health information to the 
public. The sampling method used purposive 
sampling with the help of social media 
WhatsApp and used applications google 
forms to the questionnaire and questionnaires 
manually because some areas plagued the 
Internet network. This research activity was 
carried out for one month, from January 7, 
2021, to February 8, 2021. The data analysis 




Table 1. Univariate test results 
Univariate N (85) %  
Age   
24-31 years 46 54.1 
32-40 years 26 30.6 
41-49 years 10 11.8 
50-58 years 3 3.5 
Gender   
Male 24 28.2 
Female 61 71.8 
Marital Status   
Married 63 74.1 
Alone 22 25.9 
Religion   
Protestant Christians 70 82.4 
Islam 8 9.4 
Catholic Christian 7 8.2 
Education Level   
Diploma 47 55.2 
Bachelor 10 11.8 
Bachelor and Profession 
degree 
26 30.6 
Master 2 2.4 
Occupation   
Nurse 65 76.5 
Dental Nurse 1 1.2 
Midwife 7 8.2 
Epidemiologist 4 3.5 
Administration and Health 
Policy Personnel 
4 4.7 
Doctors 5 5.9 
Place of work   
Department of health 20 23.5 
Community health center 35 41.2 
Hospitals 28 32.9 
Others 2 2.4 
Willingness to vaccinate 
COVID 
  
Willing 72 84.7 
Not willing 13 15.3 
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A total of 85 respondents participated in 
this study. Most respondents in the age 
category 23-31 years as many as 46 
respondents (54.1%), with the most gender 
being women as many as 61 respondents 
(71.8%). Respondents with married status 
were also the largest respondents in this study, 
with  63 respondents (74.1%). The majority of 
religions of the respondent were Protestant 
Christians as many as 70 respondents 
(82.4%), Diploma was the highest level of 
education among respondents, namely 47 
respondents (55.2%) with the type of work as 
nurses were the most significant respondents 
with 65 respondents (76.5%). Then the most 
respondents were respondents who worked at 




Figure 1. Reasons for not being willing 
 
Based on figure 1, it is known that 
15.3% who were not willing to be vaccinated 
against COVID-19 stated that 39% of them 
refused because they had been diagnosed with 
COVID-19, and 38% of respondents refused 
because they had comorbid diseases. 
Meanwhile, the remaining 15% are not sure 
about its safety, and the remaining 8% are 
afraid of the side effects. 
 
Table 2. Comorbid diseases in respondents 
Comorbid Diseases N (5) % 
Hypertension 2 40 
Diabetes melitus 2 40 
Allergies 1 20 
A total of the 85 respondents, five 
respondents, did not want to be given the 
COVID-19 vaccine because they had 
comorbid diseases. These comorbid diseases 
include hypertension (40%), diabetes mellitus 
(40%), and allergies (20%). 
 
Table 3. Information needed regarding 
COVID-19 vaccination 
Type of information N (85) % 
Vaccines for COVID-19 
Survivors 
38 44.7 
Comorbid 37 43.5 
Safety of vaccines 7 8.2 
Side effects of vaccines 3 3.6 
 
Table 3 explains that 38 respondents 
(44.7 %) stated that they needed information 
about vaccines for those who had been 
exposed to COVID-19, 37 respondents 
(43.5%) needed information about comorbid 
COVID-19, then seven respondents (8.2%) 
needed information about the safety of the 
COVID-19 vaccine. Themselves and three 
respondents (3.6%) said they needed 
information about the vaccine's side effects. 
 
DISCUSSION 
Compared with the results of a survey 
conducted by French 33.53%, The United 
States 28.19%, India 29.2%, Vietnam 13.8%, 
Singapore 4.6%, and the Indonesia 
government, which amounted to 8% of 
rejecting the vaccine.7-9 The results of other 
surveys are not much different, which states 
that people's desire to be vaccinated is very 
low, namely 14.8%.10So the percentage of the 
results in this study was greater, which means 
that serious attention is needed to educate the 
COVID-19 vaccination. Then results of the 
vaccination results from the first dose and the 
second dose are still low in Sangihe District. 
It is necessary to carry out health promotion 
activities to change people's behavior in 
vaccination, namely by increasing 
predisposing, enabling, and reinforcing 
factors. Change someone's behavior.11 
Knowledge is important in changing a 
person's behavior. In making efforts to 
increase knowledge in the community, a 
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health promotion planning stage is needed 
through situation analysis, determining 
problem priorities, determining alternative 
problem solving, planning, and 
implementing. It so that the provision of 
health information is carried out to get 
maximum results12. But often, health 
promotion efforts are not carried out. Carry 
out these stages, which result in the goal of the 
health promotion activity not being achieved. 
Respondents are health workers who are 
also included in the reinforcing factor. Health 
workers have an essential role in delivering 
health information, especially in the Sangihe 
district. Health workers are role models in the 
health sector who are respected by the 
community. So health workers should reflect 
on the value of health to build trust and 
adherence to the vaccination program13. 
Support for health workers who master health 
information can increase success in health 
promotion activities, in this case, the 
achievement of COVID-19 vaccination. 
The health information needed to 
improve vaccination outcomes is first in the 
form of information about someone who has 
been diagnosed with COVID-19. From the 
results of data analysis, when someone has 
been diagnosed, there is no need to be 
vaccinated again. Based on the guidance from 
PAPDI, it is also stated that someone who has 
been diagnosed with COVID-19 is not 
recommended to be vaccinated against 
COVID-1914. This is because someone 
diagnosed with COVID-19 has already 
formed antibodies in that person15. But the 
latest information is currently in Indonesia 
that for COVID-19 survivors, vaccinations 
are still carried out if they have been declared 
cured with a period of more than three 
months.16 Based on the latest information, it is 
hoped that the public will understand more 
about vaccination because the latest 
regulations set by the government have gone 
through various stages and tests, so that it is 
safe to do so.  
The next health information that is 
important in improving COVID-19 
vaccination outcomes is comorbid. Many 
studies have been conducted on people who 
are positive for COVID-19. The result is that 
people suffering from the chronic disease 
have a higher risk of being infected with the 
SARS-CoV-2 virus and have a higher risk of 
dying after being infected17.This is from 
research conducted by a meta-analysis of 7 
studies on severe degrees of COVID-19 
which stated that COPD (OR = 6.42), diabetes 
mellitus (OR = 3.12), cardiovascular (OR = 
2.70), and hypertension. (OR = 1.97).18 In 
another study conducted retrospectively on 
487 COVID-19 subjects with a severe degree, 
it was also stated that age ≥ 50 years, men with 
a history of hypertension were high-risk 
factors for experiencing COVID-19.19 
Meanwhile, in another study regarding the 
mortality of COVID-19, diabetes mellitus, 
and cardiovascular disease are high-risk 
factors for the death of COVID-19 at the 
Bhakti Dharma Husada Hospital Surabaya.20 
These respondents' information only slightly 
understands, even though the respondent is a 
health worker. Respondents 'unwillingness 
was due to the respondents' lack of 
information that they understood about 
comorbid. For these comorbid reasons, many 
misunderstandings are found due to the lack 
of information they get. So far, efforts to 
increase knowledge have only focused on 
efforts to prevent COVID-19 itself, so that 
information about comorbidity is not 
specifically explained. It was explained that 
people with hypertension can be vaccinated 
on the condition that hypertension is 
controlled <140/90 with or without drugs, as 
well as diabetes mellitus that vaccines can be 
done provided that people with type 2 diabetes 
mellitus are controlled and HbA1C below 58 
mmol or 7.5% can be given the vaccine. 
Meanwhile, people with food and drug 
allergies can also vaccinate COVID-19, 
except for some antibiotic drugs such as 
neomycin, polymyxin, streptomycin, and 
gentamicin which need major attention to the 
COVID-19 vaccine14. Recent information 
states that people with hypertension with a 
blood pressure reading of <180/100 mmHg 
can still be vaccinated, while for diabetes 
sufferers, vaccination is still carried out as 
long as there are no acute complications. Even 
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the latest information also states that cancer 
and autoimmune sufferers may be vaccinated 
against COVID-19.21 Based on this, people 
who have comorbidities make themselves the 
priority for vaccination.22 
The next information is in the form of 
the safety of the COVID-19 vaccine. 
Information that needs to be conveyed is that 
before this vaccine is given widely, such as 
Sinovac or Astra Zeneca, this vaccine must 
pass four stages of testing starting from the 
preclinical stage, namely the stage where the 
vaccine is given to animals such as mice and 
monkeys. Then proceed with the first phase of 
clinical trials, namely vaccines are given to 
dozens of people who will then be assessed 
for safety, dosage, and immune system 
stimulation. Then in the second phase of 
clinical trials involving hundreds of people 
who continue the first phase. Then it was 
carried out in the third phase of clinical trials 
on thousands of people to assess the vaccine's 
efficacy. The results of the various stages of 
the test were just accepted and deserved to be 
given widely. The result of the efficacy of the 
Synovac vaccine in Brazil was 78%, in 
Turkey, it was 91.25%, and in Indonesia, it 
was 65.3%. Meanwhile, for Astra Zeneca, 
90%.23 
Important health information to be 
conveyed to the public to increase the 
vaccination rate is by providing information 
about the side effects experienced during 
vaccination. Many hoaxes are circulating in 
the community, so the explanation about this 
is very important to convey. Deddy Mulyana 
stated that the main factor of hoaxes spreading 
easily in Indonesia is the original Indonesian 
people's character.  Indonesian people are 
considered not accustomed to different 
opinions. This condition is a factor in society 
swallowing the hoax without analyzing the 
source24. Research also states that hoax which 
has been widely spread and carried out 
repeatedly through social media can form a 
public perception or opinion that the news 
conveyed is true.25 Health information is 
required for behavior change.26 
The side effects that are obtained are 
very diverse. It is due to differences in the 
condition of a person's body.27 The study 
results stated that for Sinovac, based on local 
reactions, there are two mild to moderate in 
nature, such as pain, induration, irritation, 
redness, and swelling. Then, based on the 
systemic effect, the resulting reaction 
experiences myalgia, fatigue, and fever.28 
While the side effects resulting from Astra 
Zeneca are pain or pain when pressed at the 
injection site, headache, fatigue, muscle or 
joint pain, fever, chills, and nausea.29 
 
CONCLUSION 
This study concludes that four health 
information is most needed in improving the 
achievement of COVID-19 vaccination. 
Firstly, about vaccines for COVID-19 
survivors, secondly about what kind of 
comorbid COVID-19 vaccination is worth, 
the third and fourth are the safety and side 
effects of the COVID-19 vaccine.  
It is recommended that health workers 
promote activities for the four health 
information. If provided to the public, these 
four pieces of information are expected to 
increase public knowledge, which will result 
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